Literature DB >> 6266962

Comparative neurovirulence of selected vesicular stomatitis virus temperature-sensitive mutants of complementation groups II and III.

S G Rabinowitz, J Huprikar, M C Dal Canto.   

Abstract

Weanling mice were inoculated intracerebrally with selected vesicular stomatitis virus (VSV) complementation group II and III temperature-sensitive (ts) mutants. Of the VSV ts mutants studied, only ts G32, a group III complementation mutant, appeared neurovirulent. Interestingly, neither the capacity to replicate in central nervous system tissue nor the ability to replicate in certain neurally derived continuous cell lines at semipermissive or nonpermissive temperatures appeared different among the VSV ts mutants employed. Finally, the pathological alterations in central nervous system tissue produced by VSV ts G32 were entirely different than those produced by G31 VSV ts in the group III mutant. These studies support the hypothesis that both the virological and neuropathological features produced by different VSV ts mutants are dependent upon the unique characteristics of each mutant, rather than upon a common biochemical defect shared by all members of a complementation group.

Entities:  

Mesh:

Year:  1981        PMID: 6266962      PMCID: PMC350662          DOI: 10.1128/iai.33.1.120-125.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Subacute infection with temperature-sensitive vesicular stomatitis virus mutant G41 in the central nervous system of mice. I. Clinical and virologic studies.

Authors:  S G Rabinowitz; T C Johnson; M C Dal Canto
Journal:  J Infect Dis       Date:  1979-01       Impact factor: 5.226

2.  Temperature-sensitive viruses and the etiology of chronic and inapparent infections.

Authors:  O T Preble; J S Youngner
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

3.  Maturation of viral proteins in cells infected with temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  D M Knipe; D Baltimore; H F Lodish
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

4.  Genetic characteristics of conditional lethal mutants of vesicular stomatitis virus induced by 5-fluorouracil, 5-azacytidine, and ethyl methane sulfonate.

Authors:  C R Pringle
Journal:  J Virol       Date:  1970-05       Impact factor: 5.103

5.  Subacute infection with temperature-sensitive vesicular stomatitis virus mutant G41 in the central nervous system of mice. II. Immunofluorescent, morphologic, and immunologic studies.

Authors:  M C Dal Canto; S G Rabinowitz; T C Johnson
Journal:  J Infect Dis       Date:  1979-01       Impact factor: 5.226

6.  Ultrastructural-immunohistochemical evidence for a maturation defect of temperature-sensitive G31 vesicular stomatitis virus in murine spinal cord neurons.

Authors:  M C Dal Canto; S G Rabinowitz; T C Johnson; J V Hughes
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

7.  Murine central nervous system infection by a viral temperature-sensitive mutant: a subacute disease leading to demyelination.

Authors:  M C Dal Canto; S G Rabinowitz
Journal:  Am J Pathol       Date:  1981-03       Impact factor: 4.307

8.  Virus-induced demyelination. Production by a viral temperature-sensitive mutant.

Authors:  M C Dal Canto; S G Rabinowitz; T C Johnson
Journal:  J Neurol Sci       Date:  1979-06       Impact factor: 3.181

9.  Persistent noncytocidal vesicular stomatitis virus infections mediated by defective T particles that suppress virion transcriptase.

Authors:  J J Holland; L P Villarreal
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

10.  Pathogenicity and immunogenicity for mice of temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  R R Wagner
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

View more
  5 in total

1.  Persistent infection of a temperature-sensitive G31 vesicular stomatitis virus mutant in neural and nonneural cells: biological and virological characteristics.

Authors:  J Huprikar; S G Rabinowitz; M C DalCanto; M K Rundell
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

2.  Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors.

Authors:  Gyoung Nyoun Kim; Kunyu Wu; Jiho Patrick Hong; Zain Awamleh; C Yong Kang
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

3.  Neuroattenuation of vesicular stomatitis virus through picornaviral internal ribosome entry sites.

Authors:  Arun Ammayappan; Rebecca Nace; Kah-Whye Peng; Stephen J Russell
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

4.  Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis.

Authors:  James Brett Case; Paul W Rothlauf; Rita E Chen; Natasha M Kafai; Julie M Fox; Swathi Shrihari; Broc T McCune; Ian B Harvey; Brittany Smith; Shamus P Keeler; Louis-Marie Bloyet; Emma S Winkler; Michael J Holtzman; Daved H Fremont; Sean P J Whelan; Michael S Diamond
Journal:  bioRxiv       Date:  2020-07-10

5.  Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice.

Authors:  James Brett Case; Paul W Rothlauf; Rita E Chen; Natasha M Kafai; Julie M Fox; Brittany K Smith; Swathi Shrihari; Broc T McCune; Ian B Harvey; Shamus P Keeler; Louis-Marie Bloyet; Haiyan Zhao; Meisheng Ma; Lucas J Adams; Emma S Winkler; Michael J Holtzman; Daved H Fremont; Sean P J Whelan; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2020-07-30       Impact factor: 31.316

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.